Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | ACTG2 CL E G H | 72 | 145 | ORPHA:2604 | Familial visceral myopathy | | | | 23 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | AIRE CL E G H | 326 | 360 | OMIM:240300 | AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1 | | | | 92 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | AIRE CL E G H | 326 | 360 | ORPHA:3453 | Autoimmune polyendocrinopathy type 1 | | | | 92 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | AP2S1 CL E G H | 1175 | 565 | OMIM:600740 | Hypocalciuric hypercalcemia, familial, type III | | | | 6 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | ARVCF CL E G H | 421 | 728 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 1 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | | | | 315 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CA2 CL E G H | 760 | 1373 | ORPHA:2785 | Osteopetrosis with renal tubular acidosis | | | | 29 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CASR CL E G H | 846 | 1514 | OMIM:239200 | Hyperparathyroidism, neonatal severe | | | | 272 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CASR CL E G H | 846 | 1514 | OMIM:145980 | Hypocalciuric hypercalcemia, familial, type I | | | | 272 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDC73 CL E G H | 79577 | 16783 | ORPHA:99879 | Familial isolated hyperparathyroidism | | | | 169 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDC73 CL E G H | 79577 | 16783 | OMIM:145000 | Hyperparathyroidism 1 | | | | 169 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDC73 CL E G H | 79577 | 16783 | OMIM:145001 | Hyperparathyroidism 2 | | | | 169 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDC73 CL E G H | 79577 | 16783 | ORPHA:99880 | Hyperparathyroidism-jaw tumor syndrome | | | | 169 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDC73 CL E G H | 79577 | 16783 | ORPHA:143 | Parathyroid carcinoma | | | | 169 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDC73 CL E G H | 79577 | 16783 | OMIM:608266 | Parathyroid carcinoma | | | | 169 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 2 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 102 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:276152 | Multiple endocrine neoplasia type 4 | | | | 102 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDKN1B CL E G H | 1027 | 1785 | OMIM:610755 | Multiple endocrine neoplasia, type IV | | | | 102 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 1 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CHD7 CL E G H | 55636 | 20626 | OMIM:214800 | Charge syndrome | | | | 515 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CLDN10 CL E G H | 9071 | 2033 | OMIM:617671 | Helix syndrome | | | | 3 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | COL4A5 CL E G H | 1287 | 2207 | OMIM:301050 | Alport syndrome, X-linked | | | | 678 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | COMT CL E G H | 1312 | 2228 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 6 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CYP27B1 CL E G H | 1594 | 2606 | ORPHA:289157 | Hypocalcemic vitamin D-dependent rickets | | | | 41 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CYP27B1 CL E G H | 1594 | 2606 | OMIM:264700 | Vitamin D hydroxylation-deficient rickets, type 1A | | | | 41 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | CYP2R1 CL E G H | 120227 | 20580 | ORPHA:289157 | Hypocalcemic vitamin D-dependent rickets | | | | 5 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | DGCR2 CL E G H | 9993 | 2845 | OMIM:192430 | Velocardiofacial syndrome | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | DGCR6 CL E G H | 8214 | 2846 | OMIM:192430 | Velocardiofacial syndrome | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | DGCR8 CL E G H | 54487 | 2847 | OMIM:192430 | Velocardiofacial syndrome | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | ESS2 CL E G H | 8220 | 16817 | OMIM:192430 | Velocardiofacial syndrome | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | FAM111A CL E G H | 63901 | 24725 | ORPHA:93325 | Autosomal dominant Kenny-Caffey syndrome | | | | 8 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | FAM111A CL E G H | 63901 | 24725 | OMIM:127000 | Kenny-caffey syndrome, type 2 | | | | 8 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | FOXI1 CL E G H | 2299 | 3815 | ORPHA:705 | Pendred syndrome | | | | 33 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GATA3 CL E G H | 2625 | 4172 | OMIM:146255 | Hypoparathyroidism, sensorineural deafness, and renal dysplasia | | | | 83 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GATA3 CL E G H | 2625 | 4172 | ORPHA:2237 | Hypoparathyroidism-sensorineural deafness-renal disease syndrome | | | | 83 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GCM2 CL E G H | 9247 | 4198 | ORPHA:99879 | Familial isolated hyperparathyroidism | | | | 51 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GCM2 CL E G H | 9247 | 4198 | ORPHA:2239 | Familial isolated hypoparathyroidism due to agenesis of parathyroid gland | | | | 51 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GCM2 CL E G H | 9247 | 4198 | OMIM:617343 | Hyperparathyroidism 4 | | | | 51 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GNA11 CL E G H | 2767 | 4379 | OMIM:145981 | Hypocalciuric hypercalcemia, familial, type II | | | | 16 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GNAS CL E G H | 2778 | 4392 | OMIM:174800 | McCune-Albright syndrome, somatic, mosaic | | | | 101 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:79443 | Pseudohypoparathyroidism type 1A | | | | 101 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:94089 | Pseudohypoparathyroidism type 1B | | | | 101 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:79444 | Pseudohypoparathyroidism type 1C | | | | 101 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GNAS CL E G H | 2778 | 4392 | OMIM:103580 | Pseudohypoparathyroidism, type IA | | | | 101 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GNAS CL E G H | 2778 | 4392 | OMIM:603233 | Pseudohypoparathyroidism, type IB | | | | 101 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GNAS CL E G H | 2778 | 4392 | OMIM:612462 | Pseudohypoparathyroidism, type IC | | | | 101 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GNAS CL E G H | 2778 | 4392 | OMIM:612463 | PSEUDOPSEUDOHYPOPARATHYROIDISM | | | | 101 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GNAS-AS1 CL E G H | 149775 | 24872 | OMIM:603233 | Pseudohypoparathyroidism, type IB | | | | 1 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 8 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | HADHA CL E G H | 3030 | 4801 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | | | | 99 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | HADHB CL E G H | 3032 | 4803 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | | | | 60 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231222 | Beta-thalassemia intermedia | | | | 580 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231214 | Beta-thalassemia major | | | | 580 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | HBB CL E G H | 3043 | 4827 | ORPHA:231226 | Dominant beta-thalassemia | | | | 580 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | HIRA CL E G H | 7290 | 4916 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 3 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | IRX5 CL E G H | 10265 | 14361 | OMIM:611174 | Hamamy syndrome | | | | 4 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | JMJD1C CL E G H | 221037 | 12313 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 2 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | KCNJ10 CL E G H | 3766 | 6256 | ORPHA:705 | Pendred syndrome | | | | 121 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | LIG4 CL E G H | 3981 | 6601 | ORPHA:235 | Dubowitz syndrome | | | | 88 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | MEN1 CL E G H | 4221 | 7010 | ORPHA:99879 | Familial isolated hyperparathyroidism | | | | 462 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | MEN1 CL E G H | 4221 | 7010 | ORPHA:97279 | Insulinoma | | | | 462 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 462 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | NKX2-1 CL E G H | 7080 | 11825 | ORPHA:209905 | Brain-lung-thyroid syndrome | | | | 51 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | NSUN2 CL E G H | 54888 | 25994 | ORPHA:235 | Dubowitz syndrome | | | | 84 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | OCRL CL E G H | 4952 | 8108 | ORPHA:534 | Oculocerebrorenal syndrome of Lowe | | | | 88 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | PDE4D CL E G H | 5144 | 8783 | ORPHA:280651 | Acrodysostosis with multiple hormone resistance | | | | 113 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | PIGT CL E G H | 51604 | 14938 | ORPHA:369837 | Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome | | | | 12 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | PLEKHM1 CL E G H | 9842 | 29017 | OMIM:618107 | OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3 | | | | 2 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:280651 | Acrodysostosis with multiple hormone resistance | | | | 134 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | PRMT7 CL E G H | 54496 | 25557 | OMIM:617157 | Short stature, brachydactyly, intellectual developmental disability, and seizures | | | | 6 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | PRMT7 CL E G H | 54496 | 25557 | ORPHA:464288 | Short stature-brachydactyly-obesity-global developmental delay syndrome | | | | 6 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | PTH CL E G H | 5741 | 9606 | OMIM:146200 | Hypoparathyroidism, familial isolated | | | | 16 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | PTH1R CL E G H | 5745 | 9608 | OMIM:156400 | Metaphyseal chondrodysplasia, Jansen type | | | | 58 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | RET CL E G H | 5979 | 9967 | OMIM:171400 | Multiple endocrine neoplasia, type IIA | | | | 572 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | RREB1 CL E G H | 6239 | 10449 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | SEC24C CL E G H | 9632 | 10705 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | SLC12A1 CL E G H | 6557 | 10910 | OMIM:601678 | Bartter syndrome, type 1, antenatal | | | | 75 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | SLC26A4 CL E G H | 5172 | 8818 | ORPHA:705 | Pendred syndrome | | | | 274 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | STX16 CL E G H | 8675 | 11431 | ORPHA:94089 | Pseudohypoparathyroidism type 1B | | | | 86 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | STX16 CL E G H | 8675 | 11431 | OMIM:603233 | Pseudohypoparathyroidism, type IB | | | | 86 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TBCE CL E G H | 6905 | 11582 | ORPHA:93324 | Autosomal recessive Kenny-Caffey syndrome | | | | 52 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TBCE CL E G H | 6905 | 11582 | OMIM:241410 | Hypoparathyroidism-Retardation-Dysmorphism syndrome | | | | 52 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TBCE CL E G H | 6905 | 11582 | OMIM:244460 | Kenny-caffey syndrome, type 1 | | | | 52 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TBCE CL E G H | 6905 | 11582 | ORPHA:2323 | Sanjad-Sakati syndrome | | | | 52 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TBX1 CL E G H | 6899 | 11592 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 32 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TBX1 CL E G H | 6899 | 11592 | OMIM:192430 | Velocardiofacial syndrome | | | | 32 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TBX2 CL E G H | 6909 | 11597 | OMIM:618223 | VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | UFD1 CL E G H | 7353 | 12520 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | VDR CL E G H | 7421 | 12679 | ORPHA:93160 | Hypocalcemic vitamin D-resistant rickets | | | | 104 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | VDR CL E G H | 7421 | 12679 | OMIM:277440 | Vitamin d-dependent rickets, type 2A | | | | 104 | | |
HP:0011767 | HP:0011767 | Abnormality of the parathyroid physiology | 0 | YY1 CL E G H | 7528 | 12856 | ORPHA:97279 | Insulinoma | | | | 7 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | ACTG2 CL E G H | 72 | 145 | ORPHA:2604 | Familial visceral myopathy | HP:0040283 - Occasional | | | 23 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | AIRE CL E G H | 326 | 360 | OMIM:240300 | AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS1 | | | | 92 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | AIRE CL E G H | 326 | 360 | ORPHA:3453 | Autoimmune polyendocrinopathy type 1 | HP:0040281 - Very frequent | | | 92 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | AP2S1 CL E G H | 1175 | 565 | OMIM:600740 | Hypocalciuric hypercalcemia, familial, type III | | | | 6 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | ARVCF CL E G H | 421 | 728 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | . | | | 315 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CA2 CL E G H | 760 | 1373 | ORPHA:2785 | Osteopetrosis with renal tubular acidosis | | | | 29 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CASR CL E G H | 846 | 1514 | OMIM:239200 | Hyperparathyroidism, neonatal severe | | | | 272 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CASR CL E G H | 846 | 1514 | OMIM:145980 | Hypocalciuric hypercalcemia, familial, type I | . | | | 272 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDC73 CL E G H | 79577 | 16783 | ORPHA:99879 | Familial isolated hyperparathyroidism | | | | 169 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDC73 CL E G H | 79577 | 16783 | OMIM:145000 | Hyperparathyroidism 1 | | | | 169 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDC73 CL E G H | 79577 | 16783 | OMIM:145001 | Hyperparathyroidism 2 | . | | | 169 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDC73 CL E G H | 79577 | 16783 | ORPHA:99880 | Hyperparathyroidism-jaw tumor syndrome | | | | 169 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDC73 CL E G H | 79577 | 16783 | OMIM:608266 | Parathyroid carcinoma | . | | | 169 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDC73 CL E G H | 79577 | 16783 | ORPHA:143 | Parathyroid carcinoma | | | | 169 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 2 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 102 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:276152 | Multiple endocrine neoplasia type 4 | HP:0040281 - Very frequent | | | 102 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDKN1B CL E G H | 1027 | 1785 | OMIM:610755 | Multiple endocrine neoplasia, type IV | | | | 102 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 1 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | CHD7 CL E G H | 55636 | 20626 | OMIM:214800 | Charge syndrome | | | | 515 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CLDN10 CL E G H | 9071 | 2033 | OMIM:617671 | Helix syndrome | | | | 3 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | COL4A5 CL E G H | 1287 | 2207 | OMIM:301050 | Alport syndrome, X-linked | . | | | 678 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | COMT CL E G H | 1312 | 2228 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040282 - Frequent | | | 6 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CYP27B1 CL E G H | 1594 | 2606 | ORPHA:289157 | Hypocalcemic vitamin D-dependent rickets | | | | 41 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CYP27B1 CL E G H | 1594 | 2606 | OMIM:264700 | Vitamin D hydroxylation-deficient rickets, type 1A | | | | 41 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | CYP2R1 CL E G H | 120227 | 20580 | ORPHA:289157 | Hypocalcemic vitamin D-dependent rickets | | | | 5 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | DGCR2 CL E G H | 9993 | 2845 | OMIM:192430 | Velocardiofacial syndrome | | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | DGCR6 CL E G H | 8214 | 2846 | OMIM:192430 | Velocardiofacial syndrome | | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | DGCR8 CL E G H | 54487 | 2847 | OMIM:192430 | Velocardiofacial syndrome | | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | ESS2 CL E G H | 8220 | 16817 | OMIM:192430 | Velocardiofacial syndrome | | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | FAM111A CL E G H | 63901 | 24725 | ORPHA:93325 | Autosomal dominant Kenny-Caffey syndrome | | | | 8 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | FAM111A CL E G H | 63901 | 24725 | OMIM:127000 | Kenny-caffey syndrome, type 2 | . | | | 8 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | FOXI1 CL E G H | 2299 | 3815 | ORPHA:705 | Pendred syndrome | HP:0040283 - Occasional | | | 33 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | GATA3 CL E G H | 2625 | 4172 | OMIM:146255 | Hypoparathyroidism, sensorineural deafness, and renal dysplasia | | | | 83 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | GATA3 CL E G H | 2625 | 4172 | ORPHA:2237 | Hypoparathyroidism-sensorineural deafness-renal disease syndrome | HP:0040280 - Obligate | | | 83 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | GCM2 CL E G H | 9247 | 4198 | ORPHA:99879 | Familial isolated hyperparathyroidism | | | | 51 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | GCM2 CL E G H | 9247 | 4198 | ORPHA:2239 | Familial isolated hypoparathyroidism due to agenesis of parathyroid gland | | | | 51 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | GCM2 CL E G H | 9247 | 4198 | OMIM:617343 | Hyperparathyroidism 4 | | | | 51 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | GNA11 CL E G H | 2767 | 4379 | OMIM:145981 | Hypocalciuric hypercalcemia, familial, type II | | | | 16 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | GNAS CL E G H | 2778 | 4392 | OMIM:174800 | McCune-Albright syndrome, somatic, mosaic | . | | | 101 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:79443 | Pseudohypoparathyroidism type 1A | HP:0040280 - Obligate | | | 101 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:94089 | Pseudohypoparathyroidism type 1B | HP:0040280 - Obligate | | | 101 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:79444 | Pseudohypoparathyroidism type 1C | HP:0040280 - Obligate | | | 101 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | GNAS CL E G H | 2778 | 4392 | OMIM:103580 | Pseudohypoparathyroidism, type IA | . | | | 101 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | GNAS CL E G H | 2778 | 4392 | OMIM:603233 | Pseudohypoparathyroidism, type IB | . | | | 101 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | GNAS CL E G H | 2778 | 4392 | OMIM:612462 | Pseudohypoparathyroidism, type IC | . | | | 101 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | GNAS CL E G H | 2778 | 4392 | OMIM:612463 | PSEUDOPSEUDOHYPOPARATHYROIDISM | . | | | 101 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | GNAS-AS1 CL E G H | 149775 | 24872 | OMIM:603233 | Pseudohypoparathyroidism, type IB | . | | | 1 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | GP1BB CL E G H | 2812 | 4440 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040282 - Frequent | | | 8 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | HADHA CL E G H | 3030 | 4801 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | HP:0040283 - Occasional | | | 99 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | HADHB CL E G H | 3032 | 4803 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | HP:0040283 - Occasional | | | 60 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:231222 | Beta-thalassemia intermedia | HP:0040284 - Very rare | | | 580 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:231214 | Beta-thalassemia major | HP:0040283 - Occasional | | | 580 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | HBB CL E G H | 3043 | 4827 | ORPHA:231226 | Dominant beta-thalassemia | HP:0040283 - Occasional | | | 580 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | HIRA CL E G H | 7290 | 4916 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040282 - Frequent | | | 3 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | IRX5 CL E G H | 10265 | 14361 | OMIM:611174 | Hamamy syndrome | . | | | 4 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | JMJD1C CL E G H | 221037 | 12313 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040282 - Frequent | | | 2 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | KCNJ10 CL E G H | 3766 | 6256 | ORPHA:705 | Pendred syndrome | HP:0040283 - Occasional | | | 121 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | LIG4 CL E G H | 3981 | 6601 | ORPHA:235 | Dubowitz syndrome | HP:0040283 - Occasional | | | 88 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:99879 | Familial isolated hyperparathyroidism | | | | 462 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:97279 | Insulinoma | | | | 462 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 462 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | NKX2-1 CL E G H | 7080 | 11825 | ORPHA:209905 | Brain-lung-thyroid syndrome | HP:0040284 - Very rare | | | 51 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | NSUN2 CL E G H | 54888 | 25994 | ORPHA:235 | Dubowitz syndrome | HP:0040283 - Occasional | | | 84 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | OCRL CL E G H | 4952 | 8108 | ORPHA:534 | Oculocerebrorenal syndrome of Lowe | HP:0040282 - Frequent | | | 88 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | PDE4D CL E G H | 5144 | 8783 | ORPHA:280651 | Acrodysostosis with multiple hormone resistance | HP:0040280 - Obligate | | | 113 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | PIGT CL E G H | 51604 | 14938 | ORPHA:369837 | Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome | HP:0040283 - Occasional | | | 12 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | PLEKHM1 CL E G H | 9842 | 29017 | OMIM:618107 | OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3 | | | | 2 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:280651 | Acrodysostosis with multiple hormone resistance | HP:0040280 - Obligate | | | 134 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | PRMT7 CL E G H | 54496 | 25557 | OMIM:617157 | Short stature, brachydactyly, intellectual developmental disability, and seizures | . | | | 6 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | PRMT7 CL E G H | 54496 | 25557 | ORPHA:464288 | Short stature-brachydactyly-obesity-global developmental delay syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | PTH CL E G H | 5741 | 9606 | OMIM:146200 | Hypoparathyroidism, familial isolated | | | | 16 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | PTH1R CL E G H | 5745 | 9608 | OMIM:156400 | Metaphyseal chondrodysplasia, Jansen type | . | | | 58 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | RET CL E G H | 5979 | 9967 | OMIM:171400 | Multiple endocrine neoplasia, type IIA | | | | 572 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | RREB1 CL E G H | 6239 | 10449 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040282 - Frequent | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | SEC24C CL E G H | 9632 | 10705 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040282 - Frequent | | | | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | SLC12A1 CL E G H | 6557 | 10910 | OMIM:601678 | Bartter syndrome, type 1, antenatal | HP:0040283 - Occasional | | | 75 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | SLC26A4 CL E G H | 5172 | 8818 | ORPHA:705 | Pendred syndrome | HP:0040283 - Occasional | | | 274 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | STX16 CL E G H | 8675 | 11431 | ORPHA:94089 | Pseudohypoparathyroidism type 1B | HP:0040280 - Obligate | | | 86 | | |
HP:0011767 | HP:0000852 | Pseudohypoparathyroidism | 1 | STX16 CL E G H | 8675 | 11431 | OMIM:603233 | Pseudohypoparathyroidism, type IB | . | | | 86 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TBCE CL E G H | 6905 | 11582 | ORPHA:93324 | Autosomal recessive Kenny-Caffey syndrome | | | | 52 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TBCE CL E G H | 6905 | 11582 | OMIM:241410 | Hypoparathyroidism-Retardation-Dysmorphism syndrome | | | | 52 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TBCE CL E G H | 6905 | 11582 | OMIM:244460 | Kenny-caffey syndrome, type 1 | | | | 52 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TBCE CL E G H | 6905 | 11582 | ORPHA:2323 | Sanjad-Sakati syndrome | HP:0040281 - Very frequent | | | 52 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TBX1 CL E G H | 6899 | 11592 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040282 - Frequent | | | 32 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TBX1 CL E G H | 6899 | 11592 | OMIM:192430 | Velocardiofacial syndrome | | | | 32 | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TBX2 CL E G H | 6909 | 11597 | OMIM:618223 | VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION | . | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | HP:0040284 - Very rare | | | | | |
HP:0011767 | HP:0000829 | Hypoparathyroidism | 1 | UFD1 CL E G H | 7353 | 12520 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040282 - Frequent | | | | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | VDR CL E G H | 7421 | 12679 | ORPHA:93160 | Hypocalcemic vitamin D-resistant rickets | HP:0040281 - Very frequent | | | 104 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | VDR CL E G H | 7421 | 12679 | OMIM:277440 | Vitamin d-dependent rickets, type 2A | | | | 104 | | |
HP:0011767 | HP:0000843 | Hyperparathyroidism | 1 | YY1 CL E G H | 7528 | 12856 | ORPHA:97279 | Insulinoma | | | | 7 | | |
HP:0011767 | HP:0011771 | Autoimmune hypoparathyroidism | 2 | CL E G H | | | | | | | | | | |
HP:0011767 | HP:0011770 | Tertiary hyperparathyroidism | 2 | CL E G H | | | | | | | | | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | AP2S1 CL E G H | 1175 | 565 | OMIM:600740 | Hypocalciuric hypercalcemia, familial, type III | . | | | 6 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0011767 | HP:0000867 | Secondary hyperparathyroidism | 2 | CA2 CL E G H | 760 | 1373 | ORPHA:2785 | Osteopetrosis with renal tubular acidosis | | | | 29 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | CASR CL E G H | 846 | 1514 | OMIM:239200 | Hyperparathyroidism, neonatal severe | . | | | 272 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | CDC73 CL E G H | 79577 | 16783 | ORPHA:99879 | Familial isolated hyperparathyroidism | HP:0040281 - Very frequent | | | 169 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | CDC73 CL E G H | 79577 | 16783 | OMIM:145000 | Hyperparathyroidism 1 | . | | | 169 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | CDC73 CL E G H | 79577 | 16783 | ORPHA:99880 | Hyperparathyroidism-jaw tumor syndrome | HP:0040280 - Obligate | | | 169 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | CDC73 CL E G H | 79577 | 16783 | ORPHA:143 | Parathyroid carcinoma | HP:0040280 - Obligate | | | 169 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040281 - Very frequent | | | 2 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040281 - Very frequent | | | 102 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | CDKN1B CL E G H | 1027 | 1785 | OMIM:610755 | Multiple endocrine neoplasia, type IV | | | | 102 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040281 - Very frequent | | | 1 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040281 - Very frequent | | | | | |
HP:0011767 | HP:0000867 | Secondary hyperparathyroidism | 2 | CYP27B1 CL E G H | 1594 | 2606 | ORPHA:289157 | Hypocalcemic vitamin D-dependent rickets | HP:0040281 - Very frequent | | | 41 | | |
HP:0011767 | HP:0000867 | Secondary hyperparathyroidism | 2 | CYP27B1 CL E G H | 1594 | 2606 | OMIM:264700 | Vitamin D hydroxylation-deficient rickets, type 1A | . | | | 41 | | |
HP:0011767 | HP:0000867 | Secondary hyperparathyroidism | 2 | CYP2R1 CL E G H | 120227 | 20580 | ORPHA:289157 | Hypocalcemic vitamin D-dependent rickets | HP:0040281 - Very frequent | | | 5 | | |
HP:0011767 | HP:0008198 | Congenital hypoparathyroidism | 2 | FAM111A CL E G H | 63901 | 24725 | ORPHA:93325 | Autosomal dominant Kenny-Caffey syndrome | HP:0040282 - Frequent | | | 8 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | GCM2 CL E G H | 9247 | 4198 | ORPHA:99879 | Familial isolated hyperparathyroidism | HP:0040281 - Very frequent | | | 51 | | |
HP:0011767 | HP:0008198 | Congenital hypoparathyroidism | 2 | GCM2 CL E G H | 9247 | 4198 | ORPHA:2239 | Familial isolated hypoparathyroidism due to agenesis of parathyroid gland | HP:0040280 - Obligate | | | 51 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | GCM2 CL E G H | 9247 | 4198 | OMIM:617343 | Hyperparathyroidism 4 | . | | | 51 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | GNA11 CL E G H | 2767 | 4379 | OMIM:145981 | Hypocalciuric hypercalcemia, familial, type II | . | | | 16 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | MEN1 CL E G H | 4221 | 7010 | ORPHA:99879 | Familial isolated hyperparathyroidism | HP:0040281 - Very frequent | | | 462 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | MEN1 CL E G H | 4221 | 7010 | ORPHA:97279 | Insulinoma | HP:0040282 - Frequent | | | 462 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040281 - Very frequent | | | 462 | | |
HP:0011767 | HP:0008198 | Congenital hypoparathyroidism | 2 | TBCE CL E G H | 6905 | 11582 | ORPHA:93324 | Autosomal recessive Kenny-Caffey syndrome | HP:0040281 - Very frequent | | | 52 | | |
HP:0011767 | HP:0008198 | Congenital hypoparathyroidism | 2 | TBCE CL E G H | 6905 | 11582 | OMIM:241410 | Hypoparathyroidism-Retardation-Dysmorphism syndrome | . | | | 52 | | |
HP:0011767 | HP:0008198 | Congenital hypoparathyroidism | 2 | TBCE CL E G H | 6905 | 11582 | OMIM:244460 | Kenny-caffey syndrome, type 1 | . | | | 52 | | |
HP:0011767 | HP:0008198 | Congenital hypoparathyroidism | 2 | TBCE CL E G H | 6905 | 11582 | ORPHA:2323 | Sanjad-Sakati syndrome | HP:0040281 - Very frequent | | | 52 | | |
HP:0011767 | HP:0000867 | Secondary hyperparathyroidism | 2 | VDR CL E G H | 7421 | 12679 | OMIM:277440 | Vitamin d-dependent rickets, type 2A | . | | | 104 | | |
HP:0011767 | HP:0008200 | Primary hyperparathyroidism | 2 | YY1 CL E G H | 7528 | 12856 | ORPHA:97279 | Insulinoma | HP:0040282 - Frequent | | | 7 | | |